| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |